Skip to content

Effect of drug oral furosemide on post delivery blood pressure in women with Hypertensive Disorders in Pregnancy.

Effect of oral furosemide on postpartum blood pressure in women with Hypertensive Disorders in Pregnancy: A Randomised Controlled Trial - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095912
Enrollment
90
Registered
2025-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O140- Mild to moderate pre-eclampsia

Interventions

Intervention1: Oral furosemide: Single dose of 40mg oral furosemide is to be given 8hrs after delivery. Assessment for symptoms,hospital course, bp trends,need for potential hospital visit is done af

Sponsors

Dr Maheshwari GK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women diagnosed with Hypertensive Disorder of pregnancy including gestational hypertension preeclampsia with or without severe features Hemodynamically stable patients who delivered a foetus of more than twenty week period of gestation

Exclusion criteria

Exclusion criteria: History of allergic reaction to furosemide Hypotension Hypokalaemia Women who received diuretics before randomisation High risk comorbidities for which treatment may be indicated like overt diabetes mellitus chronic kidney disease cardiac disorders of pregnancy

Design outcomes

Primary

MeasureTime frame
Prevalence of persistent hypertension 72 hours postpartum or at the time of dischargeTimepoint: 72hours postpartum

Secondary

MeasureTime frame
Percentage of postpartum BP in severe range Need for any additional anti Hypertensive medication postpartum Postpartum length of stay Postpartum readmissionTimepoint: 72 hours postpartum

Countries

India

Contacts

Public ContactDr Mrutyunjaya B Bellad
belladmb@gmail.com9448124893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026